A5088405436- Asthma and respiratory diseases
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Pregnancy and Medication Impact
- Respiratory and Cough-Related Research
- Pharmaceutical Practices and Patient Outcomes
- Respiratory Support and Mechanisms
- Pharmaceutical studies and practices
- Medication Adherence and Compliance
- Inhalation and Respiratory Drug Delivery
- Eosinophilic Esophagitis
- Pregnancy and preeclampsia studies
- Pneumonia and Respiratory Infections
- Breastfeeding Practices and Influences
- Atrial Fibrillation Management and Outcomes
- Neonatal Respiratory Health Research
- Venous Thromboembolism Diagnosis and Management
- Bipolar Disorder and Treatment
- Maternal Mental Health During Pregnancy and Postpartum
- Reproductive System and Pregnancy
- Diabetes Management and Research
- Health Literacy and Information Accessibility
- Diabetes Treatment and Management
- Birth, Development, and Health
- Chronic Disease Management Strategies
- Health Systems, Economic Evaluations, Quality of Life
Université de Montréal
2016-2025
Centre Hospitalier Universitaire de Sherbrooke
2013-2022
Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal
2017-2022
Centre intégré universitaire de santé et de services sociaux du Nord-de-l’Île-de-Montréal
2020-2022
Hôpital du Sacré-Cœur de Montréal
2006-2020
Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean
2020
Université Laval
2020
The Quebec Population Health Research Network
2020
Quebec Research and Development Centre
2020
Université de Sherbrooke
2014-2017
To determine whether the use of inhaled corticosteroids during pregnancy increases risk induced hypertension and pre-eclampsia among asthmatic women.Nested case-control study.Three administrative health databases from Quebec: RAMQ, MED-ECHO, Fichier des evenements demographiques.3505 women with asthma, totalling 4593 pregnancies, between 1990 2000.Pregnancy pre-eclampsia.302 cases 165 were identified. Use conception until date outcome was not associated an increased (adjusted odds ratio...
In this guideline update, we highlight important and new findings related to pharmacological therapy of chronic obstructive pulmonary disease (COPD) that should change clinical practice improve management. We present updated evidence, recommendations expert remarks on maintenance pharmacotherapy in patients with stable COPD. The diagnosis nonpharmacological COPD are out-of-scope for update.In who have persistent shortness breath, exercise intolerance and/or poor health status despite using...
<b>Aim:</b> To investigate whether the maternal use of different doses inhaled corticosteroids (ICSs) during first trimester pregnancy for treatment asthma increases risk congenital malformations in offspring. <b>Methods:</b> From linkage three administrative Canadian databases, a cohort 4561 pregnancies from women with who delivered between 1990 and 2000 was reconstructed. A two-stage sampling design used to acquire additional data woman's medical chart. Cases malformation were identified...
<h3>Background</h3> Asthma during pregnancy usually requires treatment with controller medications about which more safety information is needed. The objectives are to assess the impact of use long-acting β<sub>2</sub>-agonists (LABAs) and dose inhaled corticosteroids (ICSs) on prevalence low birth weight (LBW), preterm (PB) small for gestational age (SGA). <h3>Methods</h3> A cohort women asthma giving from 1998 2008 was constructed Québec (Canada) administrative databases. LBW defined as...
RATIONALE: Since the last published Canadian Thoracic Society (CTS) COPD guideline in 2007 and 2008 update – highlights for primary care, many new clinical trials have challenged treatment practices. The current position statement provides reader with an on pharmacotherapy of patients as reviewed by CTS.OBJECTIVES: objectives this are: 1) to summarize literature topics relevant pharmacological therapy stable COPD; 2) provide guidance evidence-based recommendations expert-informed key...
Most asthma patients prescribed maintenance therapies still experience periods of worsenings characterized by daytime or nighttime symptoms, an increased need for rescue medication. In fact, these episodes are highly prevalent even in with well‐controlled disease. Published literature suggests that likely represent a window opportunity during which could intervene early to prevent exacerbations further deterioration symptoms. However, current evidence most fail respond self‐manage...
Purpose: Daily adherence to inhaled corticosteroid (ICS) regimens is one of the most important factors linked achieving optimal asthma control. Motivational interviewing (MI) a client-centered communication style that focuses on enhancing intrinsic motivation engage in appropriate self-management behaviors. MI has been shown improve variety health behaviors including medication other disorders, but its efficacy for improvement ICS asthmatics yet be examined. This pilot "proof concept" trial...
Background: Obesity can be an issue for renal transplant eligibility. Semaglutide constitutes interesting choice obesity treatment, but little data exist regarding its efficacy and security among dialysis patients. Objectives: The co-primary endpoints of this study were to describe the change in body weight (%) mass index (BMI) from beginning after 3, 6, 12 months treatment participants who used semaglutide compared with a control group non-users. Secondary included description dosages...
Background: Childhood, adolescent, and young adult cancer survivors (CAYACS) face significant long-term health risks, yet adherence to follow-up (LTFU) care remains inconsistent. This study explores the concept of akrasia (i.e., acting against one’s better judgment by engaging in behaviors known be harmful or counterproductive) understand psychological, cognitive, systemic barriers influencing survivor engagement LTFU. Method: Using an ethical reflection approach based on a literature...
Chronic obstructive pulmonary disease (COPD) patient care must include confirming a diagnosis with postbronchodilator spirometry. Because of the clinical heterogeneity and reality that airflow obstruction assessed by spirometry only partially reflects severity, thorough evaluation should assessment symptom burden risk exacerbations permits implementation evidence-informed pharmacological nonpharmacological interventions. This guideline provides recommendations from comprehensive systematic...
Background: Common measures of adherence to prescribed medications derived from administrative databases reflect both patients’ and physicians’ behavior, even if the are often interpreted as reflecting only patient's adherence. Adherence inhaled corticosteroids (ICSs) has been shown be low among patients with asthma. Objective: To develop a new measure adjusted for prescription patterns evaluate extent which use ICSs in asthma is due nonadherent or suboptimal prescribing practices. Methods:...
BACKGROUND Factors influencing community pharmacists’ interventions have been identified, but little information is available regarding these factors in asthma care. OBJECTIVE To describe the type and frequency of care to identify those interventions. METHODS A pretested, self-administered questionnaire was mailed all pharmacists registered with Ordre des pharmaciens du Québec 2006. The form included questions about setting (21 questions), provision (13 responders’ characteristics (17...
Background: The use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in nephrology practice is increasingly becoming standard care patients with diabetes or those proteinuria. Objectives: primary outcome was to identify the proportion pre-dialysis chronic kidney disease (CKD) G3a, G3b, G4 prescribed an SGLT2i and describe their characteristics. Methods: This a retrospective, multicentric, cross-sectional study CKD followed at 4 clinics province Quebec, Canada. We collected data multiple...
Background: By upgrading the pharmacists' knowledge and skill set through continuing education (CE) programs, they could be better suited to contribute enhancement of management asthma. Objective: To assess impact an asthma CE program provided community pharmacists on their knowledge, intervention frequency, appropriateness medication use. Methods: Community were invited participate in a Those who displayed interest assigned either control or experimental group. Participants first group not...